Healthcare provider profile · identity verified

Loida Miranda, MD

General Practice · VEGA BAJA, PR · NPI 1366421232

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	345	131
Levothyroxine Sodium	Levothyroxine Sodium	310	90
Gabapentin	Gabapentin	305	80
Simvastatin	Simvastatin	303	106
Losartan Potassium	Losartan Potassium	242	82
Omeprazole	Omeprazole	205	55
Pantoprazole Sodium	Pantoprazole Sodium	192	40
Lisinopril	Lisinopril	169	62
Amlodipine Besylate	Amlodipine Besylate	163	61
Synthroid	Levothyroxine Sodium	159	42
Montelukast Sodium	Montelukast Sodium	158	46
Metoprolol Succinate	Metoprolol Succinate	153	52
Albuterol Sulfate Hfa	Albuterol Sulfate	148	48
Glipizide	Glipizide	144	46
Hydrochlorothiazide	Hydrochlorothiazide	136	46
Famotidine	Famotidine	135	34
Metformin Hcl	Metformin Hcl	117	43
Tramadol Hcl	Tramadol Hcl	106	30
Diclofenac Potassium	Diclofenac Potassium	103	49
Clonazepam	Clonazepam	101	17
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	100	50
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	99	suppressed
Temazepam	Temazepam	95	18
Azithromycin	Azithromycin	86	73
Rosuvastatin Calcium	Rosuvastatin Calcium	82	32
Alendronate Sodium	Alendronate Sodium	81	27
Cilostazol	Cilostazol	76	26
Enalapril Maleate	Enalapril Maleate	74	23
Allopurinol	Allopurinol	71	19
Fluticasone Propionate	Fluticasone Propionate	66	26
Alprazolam	Alprazolam	65	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	65	15
Glimepiride	Glimepiride	60	22
Irbesartan	Irbesartan	59	19
Tamsulosin Hcl	Tamsulosin Hcl	59	21
Ciprofloxacin Hcl	Ciprofloxacin Hcl	58	50
Metoprolol Tartrate	Metoprolol Tartrate	58	20
Latanoprost	Latanoprost	57	suppressed
Clopidogrel	Clopidogrel Bisulfate	56	23
Sucralfate	Sucralfate	56	11
Baclofen	Baclofen	54	30
Ezetimibe	Ezetimibe	54	24
Dexamethasone	Dexamethasone	51	36
Furosemide	Furosemide	49	20
Xarelto	Rivaroxaban	49	17
Sertraline Hcl	Sertraline Hcl	47	19
Tizanidine Hcl	Tizanidine Hcl	47	20
Atenolol	Atenolol	46	16
Pioglitazone Hcl	Pioglitazone Hcl	45	16
Synjardy	Empagliflozin/Metformin Hcl	45	13
Albuterol Sulfate	Albuterol Sulfate	44	38
Buspirone Hcl	Buspirone Hcl	43	suppressed
Carvedilol	Carvedilol	43	20
Hydralazine Hcl	Hydralazine Hcl	43	17
Methylprednisolone	Methylprednisolone	43	29
Wixela Inhub	Fluticasone Propion/Salmeterol	43	17
Breo Ellipta	Fluticasone/Vilanterol	41	suppressed
Trazodone Hcl	Trazodone Hcl	41	15
Diclofenac Sodium	Diclofenac Sodium	39	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	37	suppressed
Lansoprazole	Lansoprazole	36	suppressed
Rivastigmine	Rivastigmine	35	suppressed
Meclizine Hcl	Meclizine Hcl	33	24
Finasteride	Finasteride	32	11
Lantus	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	12
Metoclopramide Hcl	Metoclopramide Hcl	32	suppressed
Cephalexin	Cephalexin	30	24
Humalog Mix 75-25	Insulin Lispro Protamin/Lispro	30	suppressed
Memantine Hcl	Memantine Hcl	29	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	28	suppressed
Donepezil Hcl	Donepezil Hcl	27	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	11
Janumet	Sitagliptin Phos/Metformin Hcl	27	suppressed
Nabumetone	Nabumetone	27	18
Prednisone	Prednisone	27	suppressed
Duloxetine Hcl	Duloxetine Hcl	26	suppressed
Humulin N	Insulin Nph Human Isophane	26	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Trijardy Xr	Empaglifloz/Linaglip/Metformin	25	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	24	suppressed
Farxiga	Dapagliflozin Propanediol	24	suppressed
Lorazepam	Lorazepam	23	suppressed
Mupirocin	Mupirocin	23	19
Naproxen	Naproxen	23	11
Zolpidem Tartrate	Zolpidem Tartrate	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Eliquis	Apixaban	21	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	21	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Nifedipine Er	Nifedipine	21	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	20	17
Pravastatin Sodium	Pravastatin Sodium	20	suppressed
Ramipril	Ramipril	20	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	20	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	19	16
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	19	suppressed
Jardiance	Empagliflozin	19	suppressed
Methotrexate	Methotrexate Sodium	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	17
Atrovent Hfa	Ipratropium Bromide	18	suppressed
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	18	suppressed
Fluconazole	Fluconazole	18	15
Lovastatin	Lovastatin	18	suppressed
Risperidone	Risperidone	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	17	suppressed
Jentadueto	Linagliptin/Metformin Hcl	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Amoxicillin	Amoxicillin	16	15
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Linzess	Linaclotide	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Dilantin	Phenytoin Sodium Extended	15	suppressed
Estazolam	Estazolam	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Sure Comfort	Syring-Needl,disp,insul,0.3 Ml	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Carbamazepine Er	Carbamazepine	14	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	14	suppressed
Ibandronate Sodium	Ibandronate Sodium	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Repaglinide	Repaglinide	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	13	suppressed
Ketorolac Tromethamine	Ketorolac Tromethamine	13	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Mometasone Furoate	Mometasone Furoate	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Ciclopirox	Ciclopirox	12	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Spironolactone	Spironolactone	12	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error